PNC Financial Services Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-24,549
| Closed | -$1.66M | – | 4216 |
|
|
2019
Q3 | $1.66M | Sell |
24,549
-9,180
| -27% | -$630K | ﹤0.01% | 1052 |
|
|
2019
Q2 | $1.96M | Sell |
33,729
-1,286
| -4% | -$76.2K | ﹤0.01% | 1022 |
|
|
2019
Q1 | $2.45M | Sell |
35,015
-4,917
| -12% | -$365K | ﹤0.01% | 963 |
|
|
2018
Q4 | $2.57M | Sell |
39,932
-890
| -2% | -$62.4K | ﹤0.01% | 911 |
|
|
2018
Q3 | $2.87M | Buy |
40,822
+40,088
| +5,462% | +$2.35M | ﹤0.01% | 945 |
|
|
2018
Q2 | $38K | Buy |
734
+382
| +109% | +$15.2K | ﹤0.01% | 3174 |
|
|
2018
Q1 | $10K | Sell |
352
-1,408
| -80% | -$46.7K | ﹤0.01% | 3728 |
|
|
2017
Q4 | $60K | Buy |
1,760
+49
| +3% | +$1.56K | ﹤0.01% | 2847 |
|
|
2017
Q3 | $55K | Sell |
1,711
-197
| -10% | -$6.21K | ﹤0.01% | 2880 |
|
|
2017
Q2 | $62K | Sell |
1,908
-182
| -9% | -$5.76K | ﹤0.01% | 2790 |
|
|
2017
Q1 | $66K | Sell |
2,090
-1,601
| -43% | -$47.4K | ﹤0.01% | 2756 |
|
|
2016
Q4 | $108K | Sell |
3,691
-1,867
| -34% | -$56.9K | ﹤0.01% | 2424 |
|
|
2016
Q3 | $161K | Sell |
5,558
-2,351
| -30% | -$65.5K | ﹤0.01% | 2214 |
|
|
2016
Q2 | $205K | Sell |
7,909
-284
| -3% | -$7.54K | ﹤0.01% | 2072 |
|
|
2016
Q1 | $202K | Buy |
8,193
+3,210
| +64% | +$88.1K | ﹤0.01% | 2102 |
|
|
2015
Q4 | $175K | Sell |
4,983
-7,300
| -59% | -$196K | ﹤0.01% | 2169 |
|
|
2015
Q3 | $260K | Buy |
12,283
+1,366
| +13% | +$35.2K | ﹤0.01% | 1954 |
|
|
2015
Q2 | $303K | Buy |
10,917
+2,308
| +27% | +$65.1K | ﹤0.01% | 1946 |
|
|
2015
Q1 | $263K | Buy |
8,609
+428
| +5% | +$13.6K | ﹤0.01% | 2033 |
|
|
2014
Q4 | $261K | Sell |
8,181
-1,350
| -14% | -$43.9K | ﹤0.01% | 1914 |
|
|
2014
Q3 | $270K | Sell |
9,531
-220
| -2% | -$6.13K | ﹤0.01% | 1820 |
|
|
2014
Q2 | $267K | Buy |
9,751
+2,615
| +37% | +$69.6K | ﹤0.01% | 1761 |
|
|
2014
Q1 | $188K | Buy |
7,136
+1,136
| +19% | +$32.6K | ﹤0.01% | 1922 |
|
|
2013
Q4 | $176K | Sell |
6,000
-4,000
| -40% | -$127K | ﹤0.01% | 1934 |
|
|
2013
Q3 | $306K | Hold |
10,000
| – | – | ﹤0.01% | 1627 |
|
|
2013
Q2 | $317K | Buy |
+10,000
| New | +$328K | ﹤0.01% | 1543 |
|
PNC Financial Services Group's GHDX Position: Q4 2019 in Review
PNC Financial Services Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 24,549 shares — an estimated $1.66M sold.
PNC Financial Services Group first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $2.87M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- PNC Financial Services Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- PNC Financial Services Group sold 24,549 Genomic Health, Inc. shares in Q4 2019, an estimated $1.66M.
- PNC Financial Services Group first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- PNC Financial Services Group's Genomic Health, Inc. position peaked at $2.87M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.